SRI International Expands Bio Activity to East Coast with Opening of Virginia Facility

The $22 million Center for Advanced Drug Research will apply proteomics-based technologies to understand host-vector pathogen interactions in infectious disease.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.